CARRYGENES BIOENGINEERING, LLC
Artificial Chromosome Expression (ACE) System—a mammalian artificial chromosome platform for large-payload gene delivery and cellular engineering
- Sector
- Biotech
- Total capital
- $1.1M
- Federal grants
- $999K
- 1 award · 2015
- Rank in peer group#305 of 326
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $101K
- 1 award · Interior
- Rank in Biotech#328 of 4373
- Granted patents
- 1
- 16 pending · first 2026
- Rank in peer group#80 of 326
Capital timeline
Latest events
- Federal grantDefense · Phase II · Advanced Tools for Mammalian Genome Engineering$999K
- Federal contractInterior · Igf::ot::igf Synploid Biotek Llc 13.B Phase I$101K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 326 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#80 · top 25%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 17- PendingTcd34 And Other Markers For Identification And Sorting Of Cells And For Use As In Vivo Tracking AssistantUSPTOApplication 18685881
- GrantedCompositions and Methods of Chromosomal SilencingUSPTOUS 12,522,843
- PendingSafety Kill Switches for Engineered Cells Carrying Synthetic ChromosomesUSPTOApplication 18685908
Show all 17 patent records
- Tcd34 And Other Markers For Identification And Sorting Of Cells And For Use As In Vivo Tracking AssistantMay 7, 2026 · Application 18685881Pending
- Compositions and Methods of Chromosomal SilencingJan 13, 2026 · US 12,522,843Granted
- Safety Kill Switches for Engineered Cells Carrying Synthetic ChromosomesDec 18, 2025 · Application 18685908Pending
- Use Of Chemokine Receptors In Cellular HomingJun 5, 2025 · Application 18685905Pending
- Synthetic Chromosome Encoding Two Or More Chimeric Antigen Receptors Binding To Tumor Associated AntigensJun 5, 2025 · Application 18685914Pending
- Lineage Reporter Synthetic Chromosomes And Methods Of UseMay 29, 2025 · Application 18520555Pending
- Synthetic Chromosomes Expressing Biosynthetic PathwaysJan 2, 2025 · Application 18217601Pending
- Use Of Growth Factors For T Cell ActivationNov 28, 2024 · Application 18685902Pending
- Methods of Cell RenewalMay 12, 2022 · Application 17582609Pending
- Compositions And Methods For Monitoring In Real-time Construction And Bioengineering Of Mammalian Synthetic ChromosomesJan 27, 2022 · Application 17482307Pending
- Carpool Comprising A Multitude Of CarsApplication PCTUS2022075522Pending
- Safety Switches For Engineered Cells Carrying Synthetic ChromosomesApplication PCTUS2022075525Pending
- Gene-based Medicines And Cellular Therapy For DiseaseApplication 63655597Pending
- Use Of Chemokine Receptors In Cellular HomingApplication PCTUS2022075520Pending
- Use Of Growth Factors For T Cell ActivationApplication PCTUS2022075513Pending
- TCD34 And Other Markers For Identification And Sorting Of Cells And For Used In Vivo Tracking AssistantApplication PCTUS2022075512Pending
- Compositions And Methods For Gene Therapy Using A Synthetic ChromosomeApplication 63238736Pending
Related companies, and why
- SeromYx Systems, Inc.Similar federal contract value in Biotech · $107K in contracts
- Xona Microfluidics, Inc.Similar federal contract value in Biotech · $104K in contracts
- IMANIS LIFE SCIENCES, LLCSimilar federal contract value in Biotech · $101K in contracts
- EXEMPLAR GENETICS, LLCSimilar federal contract value in Biotech · $101K in contracts
- SYNZYME TECHNOLOGIES LLCSimilar federal contract value in Biotech · $100K in contracts
- B-MoGen Biotechnologies IncSimilar federal contract value in Biotech · $100K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .